BRAFi‐associated panniculitis – an emerging side effect with a variable histological picture: report of two cases and review of the literature
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cutaneous Pathology"
DOI: 10.1111/cup.12857
Abstract: To the Editor , BRAF inhibitors (BRAFi) vemurafenib and dabrafenib have become the standard of care of metastatic melanoma. Well-described cutaneous side effects include secondary tumors such as squamous cell carcinomas and secondary melanomas and… read more here.
Keywords: literature; brafi; panniculitis emerging; brafi associated ... See more keywords